Lataa...
Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19
The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) rapidly turned into an unprecedented pandemic of coronavirus disease 2019 (COVID-19). This global healthcare emergency marked the third occurrence of a deadly coronavirus (CoV) into the human society after entering the...
Tallennettuna:
| Julkaisussa: | Front Mol Biosci |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7746807/ https://ncbi.nlm.nih.gov/pubmed/33344509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.616341 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|